Solventum Corp (SOLV): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$489.00M

Year ended 2025-12-31

$506.00M

Trailing 12 months to 2026-06-30

-5.4%

3-year compound annual growth

2022-12-31 Depreciation & Amortization (USD) 2025-12-31

Period ended	Depreciation & Amortization	Change YoY	Source filing
2025-12-31	$489.00M	-11.9%	2026-02-27, From 2025-01-01
2024-12-31	$555.00M	-1.1%	2026-02-27, From 2024-01-01
2023-12-31	$561.00M	-2.9%	2026-02-27, From 2023-01-01
2022-12-31	$578.00M	n/a	2025-02-28, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Depreciation & Amortization	Change YoY
Solventum Corp (SOLV)	2025-12-31	$489.00M	-11.9%
Baxter International Inc (BAX)	2025-12-31	$981.00M	-1.6%
ResMed Inc (RMD)	2026-06-30	$201.34M	+1.4%
Dexcom Inc (DXCM)	2025-12-31	$251.80M	+15.7%
Boston Scientific Corp (BSX)	2025-12-31	$1.37B	+7.8%
Becton Dickinson & Co (BDX)	2025-09-30	$2.46B	+7.7%
MiniMed Group, Inc. (MMED)	2026-04-24	$156.00M	+9.1%
West Pharmaceutical Services Inc (WST)	2025-12-31	$171.40M	+10.3%
Globus Medical Inc (GMED)	2025-12-31	$276.84M	+9.3%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗